EMRO has three endemic countries: Egypt, Sudan and Yemen.
The Eastern Mediterranean Neglected Tropical Diseases programme aims to prevent and control neglected tropical diseases through providing technical support to national control programmes in the planning, implementation and evaluation of control activities. The programme also coordinates international bodies to strengthen disease control and research.
According to the 2017 WHO Weekly Epidemiological Report Egypt and Yemen no longer require MDA and implemented and passed TAS3 to confirm that elimination targets have been achieved. The total population in these countries no longer requiring MDA is 2.8 million. Both countries are preparing dossiers for validation. Sudan re-started MDA in 12 of 59 known endemic IUs in 2016. Mapping surveys in Somalia identified too few W. bancrofti infections to warrant MDA but additional clinical cases requiring MMDP.
The treatment regime in all EMRO endemic countries is albendazole plus DEC (diethylcarbamazine).
The Eastern Mediterranean Programme Review Group, the body which reviews national programmes, applciations for drug donations, provides technical guidance and identifies operational research issues is chaired by:
National Nutrition Institute
General Organisation for Teaching Hospitals & Institutes
16 Kasr El Aini St
E: reda.mr.ramzy [at] gmail.com